Alexander Nyström Selected Research

Alexander Nyström Research Topics

Disease

22	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 04/2024 - 01/2013
11	Fibrosis (Cirrhosis) 04/2024 - 09/2015
9	Neoplasms (Cancer) 01/2021 - 01/2008
7	Wounds and Injuries (Trauma) 08/2021 - 01/2016
5	Inflammation (Inflammations) 05/2020 - 09/2015
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2024 - 01/2016
4	Epidermolysis Bullosa 01/2022 - 01/2013
3	Skin Diseases (Skin Disease) 01/2021 - 01/2013
2	Carcinogenesis 11/2023 - 02/2016
2	Cicatrix (Scar) 01/2022 - 01/2021
2	Blister (Bulla) 01/2022 - 11/2014
2	Muscular Dystrophies (Muscular Dystrophy) 08/2006 - 09/2005
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023
1	Myocardial Infarction 01/2023
1	Atherosclerosis 01/2023
1	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Autoimmune Lymphoproliferative Syndrome 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Bullous Pemphigoid (Pemphigoid) 01/2022
1	Common Variable Immunodeficiency 01/2022
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2022
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 06/2019
1	Congenital Abnormalities (Deformity) 01/2019
1	Adenocarcinoma 01/2019
1	Foot Deformities (Foot Deformity) 01/2019
1	Disease Progression 01/2019
1	Hypertension (High Blood Pressure) 11/2018
1	Skin Manifestations 10/2018
1	Wound Infection (Wound Infections) 01/2018
1	Papilloma (Papillomatosis) 02/2016
1	Male Infertility (Male Sterility) 09/2005

Drug/Important Bio-Agent (IBA)

18	CollagenIBA 11/2023 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
5	Collagen Type VIIIBA 11/2023 - 11/2014
4	IntegrinsIBA 01/2021 - 08/2006
3	Antisense OligonucleotidesIBA 01/2024 - 10/2016
3	ProteomeIBA 10/2021 - 01/2018
2	EnzymesIBA 01/2023 - 11/2018
2	Losartan (Cozaar)FDA LinkGeneric 01/2023 - 09/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 01/2021
2	DecorinIBA 01/2019 - 05/2009
2	Collagen Type XVIIIBA 02/2016 - 01/2016
2	Laminin (Merosin)IBA 08/2006 - 09/2005
1	Fibronectins (Fibronectin)IBA 04/2024
1	NucleotidesIBA 01/2024
1	RNA Precursors (Precursor, mRNA)IBA 01/2024
1	trametinibIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	AutoantibodiesIBA 01/2022
1	AntigensIBA 01/2022
1	Extracellular Matrix ProteinsIBA 01/2022
1	Tiopronin (Thiola)FDA Link 08/2021
1	carbomerIBA 01/2021
1	Thrombospondin 1IBA 01/2021
1	Cell Surface ReceptorsIBA 11/2020
1	AntibodiesIBA 11/2019
1	Protein AggregatesIBA 06/2019
1	Keratin-5 (Keratin 5)IBA 06/2019
1	4-phenylbutyric acid (Buphenyl)FDA Link 06/2019
1	Keratins (Keratin)IBA 06/2019
1	DisintegrinsIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2019
1	LigandsIBA 11/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Complement System Proteins (Complement)IBA 12/2017
1	RNA (Ribonucleic Acid)IBA 03/2016
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 02/2016
1	CarcinogensIBA 02/2016
1	Sirolimus (Rapamycin)FDA Link 01/2016
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2009
1	AgrinIBA 05/2009
1	Collagen Type XVIII (Type XVIII Collagen)IBA 05/2009
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 05/2009
1	Proteoglycans (Proteoglycan)IBA 05/2009
1	perlecanIBA 05/2009
1	Small Leucine-Rich ProteoglycansIBA 05/2009
1	ErbB Receptors (EGF Receptor)IBA 05/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2009
1	Integrin alpha2beta1IBA 01/2008
1	laminin alpha 2IBA 09/2005

Therapy/Procedure

11	Therapeutics 11/2023 - 01/2013
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2019 - 11/2014
1	Injections 01/2022
1	Intradermal Injections 11/2014